RoboScore
58.8
Out of 100. Its robots, plus proof from customers and the press.
5 of 6 measures have data
News bonus
5.0
From the last 90 days, up to 15
RoboIndex
63.8
Down 0.5 since the 2 Nov ranking
Rank change
No change
Now #4 of 38 in Exoskeleton · See the board →
Self-balancing robotic exoskeletons and humanoid robots
Watch Wandercraft robots at work
1 video
Is this your company? Claim it, free. Fix your record, add videos, see who looks.
Claim WandercraftMoney and customers
Raised
US$138M
Last raise · Series D · Jun 2025
Customers
1
1 L1 Announced
What the score is made of
How it worksThe score is 65% robots, 30% proof from customers and the press, 5% range of robots. Activity and readiness are shown for context.
Backed by
- AG2R LA MONDIALESeries D, 2025
Bank / other · France
2 rounds - Cemag InvestSeries D, 2025
Bank / other
2 rounds - LBO FranceSeries D, 2025
Growth / PE · France
2 rounds - Quadrant ManagementSeries D, 2025
Growth / PE · United States
2 rounds
+12 more on record.
FUNDING ROUNDS AND CUSTOMERS BY ROBOT
Bigger dot = bigger round. Hollow = amount not disclosed.
Funding rounds
- Jun 2025Series DUS$75.0MLead not disclosedNot disclosed9 outlets ↗
- Jan 2022Series CUS$45.0MLead not disclosedNot disclosed2 outlets ↗
- Oct 2017Series BUS$18.0MLead not disclosedNot disclosedThe Robot Report ↗
Rounds recorded from January 2017. Every amount links to its source.
Suggest an editCustomers
1 named customer · 1 L1 Announced. See the names
2 more customers cited in public sources
Suggest an editWandercraft is a French robotics company that develops self-balancing exoskeletons for rehabilitation and personal mobility, including Atalante X and Eve, and humanoid robots such as Calvin-40 for industrial tasks. It operates from France and has expanded commercialization efforts in the United States through partnerships and clinical programs.
Active products
3
Company facts
- HQ
- Paris, France
- Founded
- 2012 · 14 yrs
- Stage
- Series D
- Website
- en.wandercraft.eu
Active robots by Wandercraft
3 shown- 1
Atalante X54.8Surgical / Medical · 2022 · Not yet on file
- 2
Eve53.5Exoskeleton · 2020 · Not yet on file
- 3
Calvin-4047.4Exoskeleton · 2025 · Not yet on file
| # | Category | ||||
|---|---|---|---|---|---|
| 1 | ![]() | Atalante X | Surgical / Medical | 2022 | 54.8 |
| 2 | ![]() | Eve | Exoskeleton | 2020 | 53.5 |
| 3 | ![]() | Calvin-40 | Exoskeleton | 2025 | 47.4 |
In the news
6 events · last 90 days
+5.0news bonus- Oct 20Wandercraft targets global humanoid robotics leadership with 350 robots planned for Renault
- Oct 1Wandercraft Acquires Ekso Bionics from ChronoScale to Form World's Largest Medical Exoskeleton Powerhouse
- Sep 30Meet Wandercraft’s Eve: The Self-Balancing Exoskeleton
In the news
6 events · last 90 days
Why Wandercraft has been in the news, across 12 outlets, collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore (the evidence half of the RoboIndex) and it can move a robot up a board by at most 15 points.
Safety reports
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Press coverage
- Wandercraft unveils Calvin, new industrial humanoid, and Renault invests in French startup
The Robot Report
- What Sets This Exoskeleton Robot Company Apart: $137M Total ...
36Kr
- Wandercraft secures $75M in series D funds for robotics portfolio
BioWorld
- Wandercraft | Globenewswire - Via Ritzau
GlobeNewswire / Via Ritzau · Jun 2025
Milestones
Series D: raised US$75.0M
Announced Calvin-40, an industrial humanoid robot, alongside a strategic partnership with Renault Group.
Closed a $75 million Series D financing round.
Started clinical trials of the Personal Exoskeleton Eve.
Atalante X received FDA approval for spinal cord injury rehabilitation.
Atalante X was approved by the FDA for stroke rehabilitation.
Began commercial operations in the United States through a partnership with Kessler Foundation.
Series C: raised US$45.0M
- 2022launch
Launched Atalante X
- 2020launch
Launched Eve
Series B: raised US$18.0M
Exoskeleton buying guides
Industry Knowledge →
The exoskeleton vendor RFP: questions and red flags
Most exoskeleton RFPs focus on spec sheets. The questions that protect you are about fit programs, hygiene, evidence, regulatory clearance, and what happens whe…

A 90-day deployment playbook for industrial exoskeleton programs
A 90-day structured deployment — with ergonomics baseline, task selection, worker fit, hygiene protocol, and measurement — is what separates programs that scale…

Exoskeleton decision framework: passive vs. powered, industrial vs. medical
The exoskeleton market spans four device architectures, two primary buyer types, and dozens of body-region configurations. This framework maps the decision tree…
People also compare
- Fourier68.7RoboIndexCompare Wandercraft vs Fourier
- Cyberdyne61.2RoboIndexCompare Wandercraft vs Cyberdyne
- Comau75.5RoboIndexCompare Wandercraft vs Comau